Anand Varadan, Executive Vice President and Chief Commercial Officer, has left the company (news posted on July 4 2019).
Perry Monaco, who was Vice President, Sales, is promoted to Senior Vice President, Sales (news posted on July 4 2019).
Michael Mason has joined the company as Senior Vice President, Chief Financial Officer and Treasurer (news posted on February 25 2019).
Create an alert
to follow the executive moves at Karyopharm Therapeutics.
Elanco has announced the acquisition of Bayer Animal Health (posted on Aug 20, 2019).
Boston Scientific has acquired BTG (posted on Aug 19, 2019).
Glaukos has announced the acquisition of Avedro (posted on Aug 8, 2019).
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress | Karyopharm Therapeutics
Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma | Karyopharm Therapeutics
Karyopharm to Present at the Jefferies 2018 London Healthcare Conference | Karyopharm Therapeutics
Press Releases | Karyopharm Therapeutics
Karyopharm Therapeutics to Ring Nasdaq Closing Bell on November 6th | Karyopharm Therapeutics
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.